Cohort 1 data showed the increased levels of isoAsp in HSA (Fig. 1a) and the deficiency of IgGs against deamidated HSA in AD blood compared to controls (Fig. 1b), validating the results from Amsterdam cohort [17]. This evidence concerns the gene ALB and Alzheimer disease.